|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_1012 | ED148313 | General Research Use | No | Female | White | 85 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1057 | ED148057 | General Research Use | No | Male | White | 58 | 8 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_2033 | ED149227 | General Research Use | No | Male | White | 69 | 8 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2160 | ED149943 | General Research Use | No | Female | White | 66 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_2695 | ED148289 | General Research Use | No | Male | White | 71 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_3254 | ED148831 | General Research Use | No | Female | White | 66 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_3532 | ED148379 | General Research Use | No | Male | White | 56 | 8 - AREDS AMD Severity Scale Step 8 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3984 | ED148342 | General Research Use | No | Female | White | 68 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0051 | ED148934 | General Research Use | No | Male | White | 77 | 8 - AREDS AMD Severity Scale Step 8 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0088 | ED148286 | General Research Use | No | Female | White | 68 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0142 | ED148483 | General Research Use | No | Male | White | 58 | 8 - AREDS AMD Severity Scale Step 6 | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1401 | ED148529 | General Research Use | No | Female | White | 68 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1511 | ED148798 | Eye Disease Only | No | Male | White | 79 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_2041 | ED149901 | General Research Use | No | Female | White | 80 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_2219 | ED149138 | General Research Use | No | Male | White | 75 | 8 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2410 | ED148771 | General Research Use | No | Male | White | 81 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2470 | ED149205 | General Research Use | No | Female | White | 74 | 8 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2618 | ED148975 | General Research Use | No | Male | White | 74 | 8 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3060 | ED148550 | General Research Use | No | Female | White | 76 | 8 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_3232 | ED149606 | General Research Use | No | Female | White | 78 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |